Parallel Advisors, LLC Cytokinetics Inc Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 412 shares of CYTK stock, worth $19,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
412
Previous 479
13.99%
Holding current value
$19,425
Previous $25,000
16.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$692 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$555 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$457 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$367 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$305 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.44B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...